Credit: Coherus. The on-body injector includes features such as a retractable needle mechanism, an indicator, status light and auditory signal to help patients confirm the dose has been administered.

Udenyca (pegfilgrastim-cbqv) is a brand-name drug that’s prescribed for decreasing the risk of infection in people receiving chemotherapy for non-myeloid cancer and more. Udenyca comes as an injection ...

Credit: Coherus BioSciences. The new autoinjector is designed with push-on-skin activation to be used in both in-office and at-home settings of care. The Food and Drug Administration (FDA) has ...

Coherus launches Udenyca wearable injector device The on-body device delivers Udenyca, a biosimilar pegfilgrastim administered the day after chemotherapy to decrease the incidence of infection as ...

If you’re receiving cancer treatment that increases your risk of infections, your doctor might suggest Udenyca as a treatment option. It’s a prescription drug used to prevent neutropenia (a low level ...

- UDENYCA ® is the only pegfilgrastim therapy delivered in a convenient, easy-to-administer prefilled autoinjector to offer in-clinic and at-home administration options for cancer patients undergoing ...

This updated administration of Udenyca allows patients to receive this treatment in the office or at home. A single-dose, prefilled autoinjector version of Udenyca (pegfilgrastim-cbqv) has been ...

If you’re receiving chemotherapy for certain types of cancer, your doctor might suggest Udenyca as a treatment option for you. Udenyca is a prescription drug used to prevent infection in adults and ...